VBIO CIK: 1787740

Valion Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.61
FY22:
−8.92
FY23:
−8.51
FY24:
−5.73
FY25:
−7.00
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−0.01
FY23:
−0.12
FY24:
0
FY25:
−0.71
Change from FY21 to FY25
millions USD
FY21:
17.5
FY22:
−0.53
FY23:
8.51
FY24:
4.33
FY25:
18.3
millions USD
FY21:
11.9
FY22:
−9.46
FY23:
−0.12
FY24:
−1.39
FY25:
10.6
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−8.93
FY23:
−8.63
FY24:
−5.73
FY25:
−7.04

All amounts in millions USD Data source:SEC EDGAR